B7-H3-targeted CAR-T cell therapy for solid tumors
Author:
Affiliation:
1. ENT institute and Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, China
2. School of Life Science and Technology, ShanghaiTech University, Shanghai, China
Funder
Youth Foundation of National Natural Science Foundation of China
Original Exploration Project of Shanghai Natural Science Foundation
Shanghai Technology Innovation Project
Publisher
Informa UK Limited
Subject
Immunology,Immunology and Allergy
Link
https://www.tandfonline.com/doi/pdf/10.1080/08830185.2022.2102619
Reference88 articles.
1. The B7 family member B7-H3 preferentially down-regulates T helper type 1–mediated immune responses
2. B7-H3: An Attractive Target for Antibody-based Immunotherapy
3. Soluble CD276 (B7-H3) is released from monocytes, dendritic cells and activated T cells and is detectable in normal human serum
4. Structure and T Cell Inhibition Properties of B7 Family Member, B7-H3
5. Clinical significance and regulation of the costimulatory molecule B7-H3 in human colorectal carcinoma
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. An immune‐related multi‐omics analysis of dolichyl‐diphosphooligosaccharide protein glycosyltransferase in glioma: Prognostic value exploration and competitive endogenous RNA network identification;IET Systems Biology;2023-08-22
2. DNAM-1 chimeric receptor-engineered NK cells: a new frontier for CAR-NK cell-based immunotherapy;Frontiers in Immunology;2023-06-08
3. Enhancement of CAR‐T cell activity against cholangiocarcinoma by simultaneous knockdown of six inhibitory membrane proteins;Cancer Communications;2023-06-06
4. CAR T-Cell Therapy in Children with Solid Tumors;Journal of Clinical Medicine;2023-03-16
5. B7 Family Members in Pancreatic Ductal Adenocarcinoma: Attractive Targets for Cancer Immunotherapy;International Journal of Molecular Sciences;2022-11-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3